Evidence map›Paper›PMID 23493558›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Preemptive priming readily overcomes structure-based mechanisms of virus escape.

Sophie A Valkenburg, Stephanie Gras, Carole Guillonneau, Lauren A Hatton, Nicola A Bird, Kelly-Anne Twist, Hanim Halim, David C Jackson, Anthony W Purcell, Stephen J Turner and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Sophie A ValkenburgDepartment of Microbiology and Immunology, University of Melbourne, Parkville, VIC 3010, Australia.
Stephanie Gras
Carole Guillonneau
Lauren A Hatton
Nicola A Bird
Kelly-Anne Twist
Hanim Halim
David C Jackson
Anthony W Purcell
Stephen J Turner
Peter C Doherty
Jamie Rossjohn
Katherine Kedzierska
University of Melbourne · AUMonash University · AUCardiff University · GBNantes Université · FR

Funding

NIAID NIH HHS AI170251
6 · The paper itself

Abstract

A reverse-genetics approach has been used to probe the mechanism underlying immune escape for influenza A virus-specific CD8(+) T cells responding to the immunodominant D(b)NP366 epitope. Engineered viruses with a substitution at a critical residue (position 6, P6M) all evaded recognition by WT D(b)NP366-specific CD8(+) T cells, but only the NPM6I and NPM6T mutants altered the topography of a key residue (His155) in the MHC class I binding site. Following infection with the engineered NPM6I and NPM6T influenza viruses, both mutations were associated with a substantial "hole" in the naïve T-cell receptor repertoire, characterized by very limited T-cell receptor diversity and minimal primary responses to the NPM6I and NPM6T epitopes. Surprisingly, following respiratory challenge with a serologically distinct influenza virus carrying the same mutation, preemptive immunization against these escape variants led to the generation of secondary CD8(+) T-cell responses that were comparable in magnitude to those found for the WT NP epitope. Consequently, it might be possible to generate broadly protective T-cell immunity against commonly occurring virus escape mutants. If this is generally true for RNA viruses (like HIV, hepatitis C virus, and influenza) that show high mutation rates, priming against predicted mutants before an initial encounter could function to prevent the emergence of escape variants in infected hosts. That process could be a step toward preserving immune control of particularly persistent RNA viruses and may be worth considering for future vaccine strategies.

Indexed as

Models, MolecularAnimalsbeta 2-MicroglobulinBinding SitesCD8-Positive T-LymphocytesCrystallizationEpitopes, T-LymphocyteFlow CytometryGenes, MHC Class IImmune EvasionInfluenza A virusMiceMice, Inbred C57BLMutagenesis, Site-DirectedReverse Transcriptase Polymerase Chain ReactionSequence Analysis, DNAbeta 2-MicroglobulinEpitopes, T-Lymphocyte

Identifiers

PMID23493558
PMCPMC3619348
OpenAlexW2137941576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.